| Literature DB >> 33026839 |
Richard M Bergenstal1, Jennifer E Layne2, Howard Zisser3, Robert A Gabbay4, Nathan A Barleen2, Amy Armento Lee3, Amit R Majithia5, Christopher G Parkin6, Ronald F Dixon2.
Abstract
The Onduo Virtual Diabetes Clinic (VDC) for people with type 2 diabetes (T2D) combines a mobile app, remote lifestyle coaching, connected devices, and live video consultations with board-certified endocrinologists. Adults with T2D (n = 594) who were evaluated by a VDC endocrinologist, remotely prescribed and mailed a real-time continuous glucose monitoring (rtCGM) device and used ≥1 sensor completed a CGM satisfaction questionnaire. The CGM satisfaction score was 4.5 ± 0.8 out of 5. Most respondents (94.7%) agreed/strongly agreed that they were comfortable inserting the sensor remotely and that rtCGM use improved understanding of the impact of eating (97.0%), increased diabetes knowledge (95.7%), and helped improve diabetes control when not wearing the sensor (79.4%). HbA1c (n = 372) decreased from 7.7% ± 1.6% to 7.1% ± 1.2% (P < 0.001; 10.2 months). These data suggest that it is feasible to provide rtCGM directly to individuals with T2D through a VDC without in-office training. Intermittent use of rtCGM was well-received by adults with T2D and was associated with improvement in HbA1c.Entities:
Keywords: CGM; Digital health; HbA1c; Telehealth; Telemedicine; Type 2 diabetes
Year: 2020 PMID: 33026839 PMCID: PMC7868574 DOI: 10.1089/dia.2020.0396
Source DB: PubMed Journal: Diabetes Technol Ther ISSN: 1520-9156 Impact factor: 6.118